All stock lists
Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
Healthcare · Biotechnology
5.79+0.05 (+0.87%)
Insider Score
––Not scored
PHAT Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
PHAT analyst forecast
PHAT analyst consensus
No analyst ratings in the last 3 months.
PHAT 12-month price target
$15.50+167.9% upsideaverage of 2 firms
$16.00High
$15.00Low
Best analysts covering PHAT
No firm covering PHAT has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PHAT analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Craig-Hallum | — | $15.00 | +110.7% | — | 2026-10-21 | |
| Jefferies | — | $16.00 | +128.6% | — | 2026-10-14 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.